Back to EveryPatent.com
United States Patent | 5,756,550 |
Johnson ,   et al. | May 26, 1998 |
2-Amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide), or a pharmaceutically acceptable salt thereof, for use in the treatment of Parkinson's disease is disclosed.
Inventors: | Johnson; Peter (Aspley Guise, GB2); Watkins; Barry E. (Fairport, NY); Harris; Eric W. (Rochester, NY) |
Assignee: | Astra AB (Sodertalje, SE) |
Appl. No.: | 708500 |
Filed: | September 5, 1996 |
May 02, 1992[GB] | 9209599 | |
Apr 30, 1993[WO] | PCT/GB93/00908 |
Current U.S. Class: | 514/626 |
Intern'l Class: | A61K 031/165 |
Field of Search: | 514/626 |
Foreign Patent Documents | |||
0 427 427 A2 | May., 1991 | EP. |
Klockgether et al. "NMDA Antagonists potentiate. . ." Annals of Neurology, vol. 28 No. 4, 1990, pp. 539-546. R. Griffith et al. "Preclinical Neuroprotective . . ." Abstracts of Papers of the American Chemical Society, vol. 201, No. 1-2, 1991, p. 22. R.V. Eller et al. "Remacemide and L-Dopa . . ." Soc. Neurosci. Abstract, vol. 18 No. 1-2, 1992, p. 1080. Remington. Pharmaceutical Sciences, 15th Ed. Mack Pub. Co., 1995, pp. 855-857-858. |